STOCK TITAN

Mitesco gets approval to authorize 20B common shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
PRE 14C

Rhea-AI Filing Summary

Mitesco, Inc. said holders of 50.95% of its voting power approved the increase by written consent on November 18, 2026; no shareholder meeting or additional proxy is being sought. The board also approved the measure.

The approved amendment would raise authorized common stock from 500,000,000 to 20,000,000,000 shares, at $0.001 par value per share. Mitesco reported 906,396,294 shares reserved for options, warrants and other convertible instruments as of November 18, 2026. Section 14C requires mailing shareholder notice at least 20 days before the earliest date the action may be taken. The company says dilution of current holders’ earnings per share and voting rights could result to the extent additional shares are ultimately issued; the increase does not change common-stock terms.

0 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

0 major · 1 point

Hollow bars mark forward-looking points. How the balance works

Positive

  • None.

Negative

  • Moderate point. Forward-looking: it has not happened yet and may not happen.20 billion authorized shares could dilute earnings per share and voting rights if issued.

Filing Explained

Series X preferred shares supplied super-votes in the consent, with 400 votes per share.

The common-share authorization increase has been approved by written consent, but the company reports no definitive equity-funding or growth-opportunity agreement; it creates issuance capacity, not a committed issuance.

Series X preferred shares carried 400 votes each; the filing lists 36,441,200 Series X votes out of 102,922,854 total voting shares.

Authorized common stock before increase 500,000,000 shares Prior authorized amount
Authorized common stock after increase 20,000,000,000 shares Amount approved by written consent
Additional authorized common stock 19,500,000,000 shares Increase described by the company
Shares reserved for issuance 906,396,294 shares For options, warrants and other convertible instruments as of November 18, 2026
Consenting voting power 50.95% Voting power approving the increase on November 18, 2026
Series X votes per share 400 votes Series X preferred shares vote with common stockholders as a single class
as-converted basis technical
"vote together as a single class with our common stockholders on as-converted basis"
As-converted basis means counting securities that can become common stock—like convertible bonds or preferred shares—as if they already were common shares when calculating totals such as shares outstanding, ownership percentages, or per-share metrics. Investors use it to see the potential dilution and the “what-if” size of the shareholder base; it’s like imagining all restaurant coupons have been redeemed so you know how crowded the table could become and how slices of the pie would shrink.
rights of appraisal regulatory
"There are no rights of appraisal or similar rights of dissenters"
beneficial ownership regulatory
"The following table sets forth certain information regarding the beneficial ownership"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What authorized share increase did MITI shareholders approve?

MITI shareholders approved raising authorized common stock from 500,000,000 to 20,000,000,000 shares. The common stock retains its $0.001 par value and other terms.

Will MITI hold a shareholder meeting on the increase?

No shareholder meeting will be held; holders of 50.95% of voting power approved the action by written consent, and no additional consent or proxy is being requested.

How many votes does each MITI Series X preferred share carry?

Each Series X preferred share carries 400 votes and votes with common stockholders as a single class on an as-converted basis.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 14C INFORMATION

 

Information Statement Pursuant to Section 14(c)

of the Securities Exchange Act of 1934

 

Check the appropriate box:

 

☒Preliminary Information Statement

 

☐Confidential, for use of the Commission only (as permitted by Rule 14c-5(d)(2))

 

☐Definitive Information Statement

 

MITESCO, INC.

 

(Name of Registrant As Specified In Its Charter)

 

Payment of Filing Fee (Check the appropriate box):

 

☒No fee required.

 

☐Fee paid previously with preliminary materials.

 

☐Fee computed on table in exhibit required by Item 25(b) of Schedule 14A (17 CFR 240.14a-101) per Item 1 of this Schedule and Exchange Act Rules 14c-5(g) and 0-11.

 

 

 

 

 

MITESCO, INC.
505 Beachland Blvd., Suite 1377
Vero Beach, Florida 32963

NOTICE OF ACTION BY WRITTEN CONSENT OF HOLDERS OF A MAJORITY OF THE OUTSTANDING VOTING STOCK OF MITESCO, INC.

This notice and accompanying Information Statement are furnished to the holders of record of common stock, par value $0.001 per share (“Common Stock”), of MITESCO, INC., a Nevada corporation (“we,” “us,” “our” or the “Company”), pursuant to Section 14 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Regulation 14C and Schedule 14C thereunder, in connection with the approval of the action described below.

On November 5, 2026, the Board of Directors (the “Board”) approved via unanimous written consent an amendment to the Company’s Articles of Incorporation to increase the total shares of Common Stock the Company is authorized to issue from five hundred million (500,000,000) to one billion (1,000,000,000), with a par value of $0.001 per share (the “Authorized Stock Increase”), and on November 18, 2026, modified that consent to increase the authorized common stock to 20 billion (20,000,000,000). We recommended the shareholders of the Series X Preferred shares approve the Authorized Stock Increase. On November 18, 2026, shareholders holding 50.95% of Company’s voting stock, voting on as-converted basis (“Consenting Shareholders”) took this action by written consent to approve the Authorized Stock Increase.

Shareholders of record at the close of business on November 18, 2026, are entitled to notice of this shareholder action by written consent. Because this action has been approved by the holders of the required majority of the voting power of our voting stock, no proxies were or are being solicited.

Attached hereto for your review is an Information Statement relating to the Authorized Stock Increase. Please read this Information Statement carefully. It describes the essential terms of the actions to be taken. Additional information about the Company is contained in its reports filed with or furnished to the Securities and Exchange Commission (the “SEC”). The SEC maintains a website that contains reports, proxy and information statements and other information regarding public companies that file reports with the SEC. Copies of these reports may be obtained on the SEC’s website at www.sec.gov.

WE ARE NOT ASKING YOU FOR A CONSENT OR PROXY AND YOU ARE REQUESTED NOT TO SEND US A CONSENT OR PROXY. THIS IS NOT A NOTICE OF A MEETING OF SHAREHOLDERS AND NO SHAREHOLDERS’ MEETING WILL BE HELD TO CONSIDER ANY MATTER DESCRIBED HEREIN. THIS INFORMATION STATEMENT IS BEING FURNISHED TO YOU SOLELY FOR THE PURPOSE OF INFORMING YOU OF THE MATTERS DESCRIBED HEREIN.

 By Order of the Board of Directors,
  

November 20, 2026

 /s/ Mack Leath
 Mack Leath, Chairman and CEO
  
 /s/ Brian Valania
 Brian Valania, CEO
  
 /s/ Frank Panunto
 Frank Panunto, Director

 

 

MITESCO, INC.
505 Beachland Blvd., Suite 1377
Vero Beach, Florida 32963

INFORMATION STATEMENT

WE ARE NOT ASKING YOU FOR A CONSENT OR PROXY AND YOU
ARE REQUESTED NOT TO SEND US A CONSENT OR PROXY.

INTRODUCTION

Pursuant to Section 14(c) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Regulation 14C promulgated thereunder, the above notice and this information statement (the “Information Statement”) is being sent or given on or about November 18, 2026, to the shareholders of record, as of November 18, 2026 (the “Record Date”), of MITESCO, INC., a Nevada corporation (hereinafter referred to as “we,” “us,” “our,” or the “Company”). This Information Statement is being circulated to advise shareholders of certain actions already approved and taken without a meeting by written consent of shareholders who hold a majority of the voting power of our voting stock.

On November 18, 2026, our Board approved via unanimous written consent and recommended our shareholders to approve, and on November 18, 2026, shareholders holding an aggregate of 52,422,057 votes of the Company’s voting stock carrying a vote equal to 50.95% of all shares entitled to vote approved and consented in writing to the following action. These votes include votes cast by five (5), of our shareholders, who holds certain shares of common stock and 100% of Series X preferred stock. Pursuant to the rights set forth in the Series X certificate of designation, Series X preferred stockholders are entitled to vote together as a single class with our common stockholders on as-converted basis on all matters submitted to vote at a ratio of 400 votes per share of Series X preferred stock.

●The approval of an amendment to the Company’s Articles of Incorporation to increase the total shares of Common Stock the Company is authorized to issue from five hundred million (500,000,000) to twenty billion (20,000,000,000), with a par value of $0.001 per share.

 

Such approval and consent constitute the approval and consent of a majority of the total number of shares of issued and outstanding voting stock and are sufficient under the Nevada Revised Statutes (“NRS”) and our articles of incorporation and bylaws to approve the action. Accordingly, the action will not be submitted to the other shareholders of the Company for a vote, and this Information Statement is being furnished to shareholders to provide them with certain information concerning the action in accordance with the requirements of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the regulations promulgated thereunder, including Regulation 14C. This notice is also deemed to satisfy the notice requirement prescribed under the NRS.

1

 

 

ACTIONS BY BOARD OF DIRECTORS AND CONSENTING SHAREHOLDER

On November 5, 2026, the Board unanimously approved the Authorized Stock Increase. Subsequent to the Board’s approval, the Consenting Shareholders approved the Authorized Stock Increase. The Consenting Shareholders and its approximate ownership percentage of 50.95% our voting stock as of November 18, 2026, were as follows: 

Common shares outstanding at
11-18-2026 (2)
  66,481,654     Preferred X shares outstanding at
11-18-2026
    91,103     Votes from Preferred X super voting (3)     36,441,200           Total voting shares including common and super votes from Preferred X     102,922,854  
Name   Amount and Nature of Beneficial Ownership of Common Stock     Percentage of
Common Stock Beneficially Owned
    Number of
Shares of Series X Preferred Stock
    Percentage of Series X Preferred Stock     Number of
votes at 400 per share
    Add common shares
held at
11/5/2026
    Total Votes     % of the Total Votes  
MACK LEATH (1)     3,741,266       5.63 %     12,000       13.17 %     4,800,000       3,741,266       8,541,266       8.30 %
FRANK PANUNTO (1)     3,000,000       4.51 %     12,000       13.17 %     4,800,000       3,000,000       7,800,000       7.58 %
BRIAN VALANIA (1)     3,504,412       5.27 %     12,000       13.17 %     4,800,000       3,504,412       8,304,412       8.07 %
Current Executive Officers and Directors as a group (3 Persons)     10,245,678       15.41 %     36,000       39.52 %     14,400,000       10,245,678       24,645,678       23.95 %
                                                                 
5% or more shareholders                                                                
JIM CLIFTON     317,403       0.48 %     2,400       2.63 %     960,000       317,403       1,277,403       1.24 %
JORDAN BALENCIC (1)     3,421,904       5.15 %     7,200       7.90 %     2,880,000       3,421,904       6,301,904       6.12 %
JOHN MITCHELL     387,235       0.58 %     2,400       2.63 %     960,000       387,235       1,347,235       1.31 %
ANGLO IRISH MANAGEMENT, LLC (1) (4)     4,253,275       6.40 %     43,103       47.31 %     17,241,200       4,253,275       21,494,475       20.88 %
                                              Total for this vote (4)       52,442,057       50.95 %

 

(1) These individuals have voted their Common Stock and Series X Preferred shares to approve this action

 

(2) Calculated based on the 66,481,654 shares of Common Stock issued and outstanding as of November 18, 2026.

 

(3)Calculated based on 91,103 shares of Series X Preferred Stock outstanding. Each share of Series X preferred stock is entitled to 400 votes and to vote together as a single class with common stockholders on all matters submitted to a vote.

 

(4)Calculated based on 102,922,854 shares of issued and outstanding voting capital stock, including 66,481,654 shares of Common Stock, and 91,103 shares of Series X preferred stock calculated on an as-converted basis for the purposes of voting on the Authorized Stock Increase.

 

2

 

 

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

●Each person known by the Company to beneficially own more than 5% of the Company’s outstanding Common Stock;

 

●Each of the named executive officers (as defined in Item 402 of Regulation S-K);

 

●Each of our directors, and

 

●All of the Company’s executive officers and directors as a group.

 

The following table sets forth certain information regarding the beneficial ownership of our issued and outstanding Common Stock and preferred stock as of November 18, 2026, by the following persons:

Common shares outstanding at
11-18-2026 (1)
   66,481,654    Preferred X shares outstanding at
11-18-2026
    91,103    Votes from Preferred X super voting:    36,441,200         Total votng shares including common and super votes from Preferred X    102,922,854 
Name   Amount and Nature of Beneficial Ownership of Common Stock    Percentage of Common Stock Beneficially Owned    Number of Shares of Series X Preferred Stock    Percentage of Series X Preferred Stock    Number of votes at 400 per share    Add common shares held at 11/5/2026    Total Votes    % of the Total Votes 
MACK LEATH (1)   3,741,266    5.63%   12,000    13.17%   4,800,000    3,741,266    8,541,266    8.30%
FRANK PANUNTO (1)   3,000,000    4.51%   12,000    13.17%   4,800,000    3,000,000    7,800,000    7.58%
BRIAN VALANIA (1)   3,504,412    5.27%   12,000    13.17%   4,800,000    3,504,412    8,304,412    8.07%
Current Executive Officers and Directors as a group (3 Persons)   10,245,678    15.41%   36,000    39.52%   14,400,000    10,245,678    24,645,678    23.95%
5% or more shareholders                                        
JORDAN BALENCIC (1)   3,421,904    5.15%   7,200    7.90%   2,880,000    3,421,904    6,301,904    6.12%
ANGLO IRISH MANAGEMENT, LLC (1) (4)   4,253,275    6.40%   43,103    47.31%   17,241,200    4,253,275    21,494,475    20.88%
Current Executive Officers and Directors & 5% holders   17,920,857    27%   86,303    95%   34,521,200    17,920,857    52,442,057    50.95%

 

(1)Based upon 66,481,654 shares of Common Stock and 91,103 shares of Series X Preferred Stock. Each Series X Preferred Stock is entitled to 400 votes per share or an aggregate of 102,922,854 votes.

 

(2)The address for each Director is 505 Beachland Blvd., Suite 1-377, Vero Beach, FL 32963

 

Beneficial ownership is determined in accordance with the rules and regulations of the SEC. The number of shares and the percentage beneficially owned by each individual listed below include shares that are subject to options held by that individual that are immediately exercisable or exercisable within 60 days from November 18, 2026, and the number of shares and the percentage beneficially owned by all officers and directors as a group includes shares subject to options held by all officers and directors as a group that are immediately exercisable or exercisable within 60 days from November 18, 2026.

The above table assumes based on our stock records, that there are 66,481,654 shares of Common Stock and 91,103 shares of Series X Preferred Stock issued and outstanding as of November 18, 2026:

 

Security Ownership of Management and Beneficial Owners

 

Changes in Control

 

We are unaware of any contract of other arrangement the operation of which may at a subsequent date result in a change of control of our Company.

3

 

 

ACTION ONE – INCREASE IN AUTHORIZED COMMON STOCK

General

On November 18, 2026, the Board, and on November 18, 2026, the Consenting Shareholders approved the Authorized Stock Increase, which increases the total number of common stock the Company is authorized to issue from five hundred million (500,000,000) to twenty billion (20,000,000,000), with a par value of $0.001 per share.

Purpose of the Authorized Common Stock Increase

On November 18, 2026, the Board, and on November 18, 2026, the Consenting Shareholders approved the Authorized Stock Increase, which increases the total number of common stock shares which the Company is authorized to issue from five hundred million (500,000,000) to twenty billion (20,000,000,000), with a par value of $0.001 per share.

As a result of this action the Company is authorized to issue up to 20,000,000,000 shares of Common Stock. Our issued and outstanding share count was 66,481,654 as of November 18, 2026. As such, we will be authorized to issue approximately 19,933,518,346 shares to new stockholders. As of November 18, 2026, we have 906,396,294 shares reserved for issuance for options, warrants and other convertible instruments as required by the terms of our lending, and other agreements. Our Board and the Consenting Shareholders believe that an additional 19,500,000,000 increase in our authorized stock will provide the Company with additional flexibility to use its capital stock for business and financial purposes in the future. These purposes may include raising capital; establishing strategic relationships with other companies; expanding our business through the acquisition of other businesses or products; providing additional equity incentives to employees, officers or directors; and other purposes. Our Board believes that these additional shares will provide us with needed flexibility to issue shares in the future without potential expense and delay incident to obtaining Shareholder approval for a particular issuance.

We are not in any formal discussions with potential acquisition targets at the current time, and no formal agreements exist which will require the issuance of additional Common Stock as of the date of this Information Statement. However, management will need the flexibility to issue Common Stock, warrants, or preferred stock convertible into Common Stock to funders that will provide the capital required to close any future growth opportunities, as well as provide other working capital to the Company. No such definitive agreement for growth opportunities or equity funding exist at this time.

Potential Effects of Proposed Authorized Common Stock Increase

The Authorized Stock Increase will affect all holders of our Common Stock uniformly. The Authorized Stock Increase is not intended to, and will not, affect any shareholder’s percentage ownership interest in our Company, except for effects incidental to increasing the number of shares of our Common Stock outstanding, such as dilution of the earnings per share and voting rights of current holders of Common Stock, to the extent the additional Common Stock is ultimately issued.

The Authorized Stock Increase will not change the terms of our Common Stock. After the Authorized Stock Increase, the shares of our Common Stock will have the same voting rights and rights to dividends and distributions and will be identical in all other respects to our Common Stock now authorized. Our Common Stock will remain fully paid and non-assessable.

Vote Required

Pursuant to the NRS, the approval of the Authorized Stock Increase requires a majority of the Company’s outstanding voting stock. As discussed above, holders of a majority of votes of the Company’s voting stock, voting together as a class, have consented to the Authorized Stock Increase.

INTEREST OF CERTAIN PERSONS IN OR IN OPPOSITION TO MATTERS TO BE ACTED UPON

There is no substantial interest, direct or indirect, by security holdings or otherwise, of any person who has been director or officer of the Company at any time since the beginning of the last fiscal year in the Authorized Stock Increase.

4

 

PROPOSALS BY SECURITY HOLDERS

The Board knows of no other matters or proposals other than the actions described in this Information Statement that have been approved or considered by the holders of a majority of the shares of the Company’s stock.

DISSENTERS’ RIGHTS

There are no rights of appraisal or similar rights of dissenters with respect to any matter described in this Information Statement.

RECORD DATE AND VOTING SECURITIES

Only shareholders of record at the close of business on the Record Date are entitled to notice of the information disclosed in this Information Statement. As of the Record Date, our authorized common shares consist of five hundred million (500,000,000) shares of Common Stock with a par value of $0.001 per share. As of the Record Date, there were 60,153,708 shares of Common Stock and 91,108 shares of Series X preferred stock issued and outstanding. Each share of Common Stock is entitled to one vote per share. Each share of Preferred Stock is entitled to 400 votes per share and can vote alongside common stockholders as a single class.

EXPENSES

The costs of preparing, printing and mailing this Information Statement will be borne by the Company.

THIS IS NOT A NOTICE OF A MEETING OF SHAREHOLDERS AND NO SHAREHOLDERS’ MEETING WILL BE HELD TO CONSIDER ANY MATTER DESCRIBED HEREIN. THIS INFORMATION STATEMENT IS BEING FURNISHED TO YOU SOLELY FOR THE PURPOSE OF INFORMING YOU OF THE MATTERS DESCRIBED HEREIN.

SHAREHOLDERS’ RIGHTS

The elimination of the need for a special meeting of the shareholders to approve the actions described in this Information Statement is authorized by the Nevada Revised Statutes (“NRS”). The NRS provides that any action required or permitted to be taken at a meeting of shareholders of a corporation may be taken without a meeting, if a written consent thereto is signed by holders of outstanding shares having not less than the minimum number of votes that would be necessary to authorize or take that action at a meeting at which all shares entitled to vote thereon were present and voted. In order to eliminate the costs and management time involved in holding a special meeting and in order to effect the action disclosed herein as quickly as possible in order to accomplish the purposes of our Company, we chose to obtain the written consent of a majority of our voting power to approve the action described in this Information Statement.

ADDITIONAL INFORMATION

We are subject to the disclosure requirements of the Exchange Act, and in accordance therewith, file reports, information statements and other information, including annual and quarterly reports on Form 10-K and 10-Q, respectively, with the SEC. The SEC maintains a website (http://www.sec.gov) that contains reports, information statements and other information regarding issuers that file electronically with the SEC through the EDGAR system, where reports and other information filed or furnished by us can be inspected. You may also request a copy of documents filed with or furnished to the SEC by us, at no cost, by writing to MITESCO, INC., 505 Beachland Blvd., Suite 1377, Vero Beach, Florida 32963, Attn: Mack Leath, Chairman and CEO, or by telephoning the Company at 844-383-8689.

Our principal executive office is located at 505 Beachland Blvd., Suite 1377, Vero Beach, Florida 32963. Our corporate website is https://www.mitesco.com/ and our phone number is 844-383-8689.

5

 

NOTICE OF INTERNET AVAILABILITY OF INFORMATION STATEMENT

Under the Securities and Exchange Commission rules, you are receiving notice that this Information Statement is also available on the Internet. You may access the Information Statement online at https://www.sec.gov/edgar/browse/?CIK=802257&owner=exclude. When you go online, you can also help the environment by consenting to receive electronic delivery of future materials.

DELIVERY OF DOCUMENTS TO SECURITY HOLDERS SHARING AN ADDRESS

If hard copies of the materials are requested, we will send only one Information Statement and other corporate mailings to shareholders who share a single address unless we received contrary instructions from any shareholder at that address. This practice, known as “householding,” is designed to reduce our printing and postage costs. However, the Company will deliver promptly upon written or oral request a separate copy of the Information Statement to a shareholder at a shared address to which a single copy of the Information Statement was delivered. You may make such a written or oral request by (a) sending a written notification stating (i) your name, (ii) your shared address and (iii) the address to which the Company should direct the additional copy of the Information Statement, to MITESCO, INC., 505 Beachland Blvd., Suite 1377, Vero Beach, Florida 32963, Attn: Mack Leath, Chairman and CEO, or by telephoning the Company at 844-383-8689.

If multiple shareholders sharing an address have received one copy of this Information Statement or any other corporate mailing and would prefer the Company to mail each shareholder a separate copy of future mailings, you may mail notification to, or call the Company at, its principal executive offices. Additionally, if current shareholders with a shared address received multiple copies of this Information Statement or other corporate mailings and would prefer the Company to mail one copy of future mailings to shareholders at the shared address, notification of such request may also be made by mail or telephone to the Company’s principal executive offices.

NO ADDITIONAL ACTION IS REQUIRED BY OUR SHAREHOLDERS IN CONNECTION WITH THESE ACTIONS. HOWEVER, SECTION 14C OF THE EXCHANGE ACT REQUIRES THE MAILING TO OUR SHAREHOLDERS OF THE INFORMATION SET FORTH IN THIS INFORMATION STATEMENT AT LEAST 20 DAYS PRIOR TO THE EARLIEST DATE ON WHICH THE CORPORATE ACTION MAY BE TAKEN.

 MITESCO, INC.
  
November 20, 2026/s/ Mack Leath
 Mack Leath
 Chairman

 

6

Keep reading